NEW DELHI, Aug. 13 (UPI) — India officials are protesting a British study blaming India for exporting a drug-resistant bacteria to the rest of the world and naming it for an Indian city.
A report from British researchers dubbed the superbug “New Delhi metallo beta lactamase” or NDM-1, the Hindustani Times reported Friday.
“India strongly refutes the naming of this enzyme as New Delhi metallo beta lactamase (NDM-1) and also refutes that hospitals in India are not safe for treatment, including medical tourism,” a statement from India’s Union Health Ministry said.
“It is ridiculous to call it NDM-1 when none of the samples that tested positive were picked in New Delhi,” said Dr Naresh Trehan.
His position was supported by another Indian health official.
“Getting infection by such drug-resistant bacteria is a matter of chance and can happen anywhere,” Dr. V.M. Katoch of the department of health research said.
“A national resistance alert was issued in U.K. hospitals in July 2009, and a similar alert has been sounded now. Similar super bugs have been reported from Israel, the United States, Greece and Scotland,” Katoch said.
Copyright 2010 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI’s prior written consent.